[News] New triple-negative breast cancer risk genes identified

[News] New triple-negative breast cancer risk genes identified

by Elizabeth Gourd

The Lancet Oncology : News: Volume 19, issue 9 PE445, September 01, 2018

Multigene hereditary cancer panel testing could be used to identify women with an elevated risk of triple-negative breast cancer as a result of deleterious mutations in five genes, according to a recent study.

Breast Cancer Genetics for Plastic Surgeons

Breast Cancer Genetics for Plastic Surgeons
McInerney, N et al

Plastic & Reconstructive Surgery: September 2017 - Volume 140 - Issue 3 - p 455–460

Summary: Multidisciplinary genetic clinics offer counseling and testing to those who meet criteria for familial breast cancer, and plastic surgeons become integral to this process when risk-reducing surgery and postmastectomy reconstruction are deemed appropriate. As reconstructive surgeons, it is important that plastic surgeons are aware of the risks and issues associated with the genetic variants that cause patients to present for prophylactic or therapeutic surgery.